These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19393953)

  • 21. The poor quality of streptokinase products in use in developing countries.
    Longstaff C; Thelwell C; Whitton C
    J Thromb Haemost; 2005 May; 3(5):1092-3. PubMed ID: 15869616
    [No Abstract]   [Full Text] [Related]  

  • 22. Patents and the quality, safety and efficacy of medicines.
    du Toit K; du Preez W; Padayachee S
    S Afr Med J; 2015 Nov; 105(11):905-6. PubMed ID: 26632315
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality assurance during the production process.
    Tucker JD
    Med Serv J Can; 1967 Mar; 23(3):262-9. PubMed ID: 6056371
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 25. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quality control in the pharmaceutical industry].
    Bretscher E
    Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535
    [No Abstract]   [Full Text] [Related]  

  • 27. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 29. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drugs in the 3d World. Every profession has its share of responsibility].
    Rosenkvist I
    Sygeplejersken; 1983 Jun; 83(21):24-6. PubMed ID: 6555952
    [No Abstract]   [Full Text] [Related]  

  • 32. Combating counterfeit drugs.
    Land T
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731208
    [No Abstract]   [Full Text] [Related]  

  • 33. Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
    Wang N; Lipworth WL; Ritchie JE; Williams KM; Day RO
    Intern Med J; 2011 Apr; 41(4):314-20. PubMed ID: 20403068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting GMP implementation: developing training materials for the international audience.
    Morimoto K; Curry J; Kopp S; Rägo L; van Zyl A; Wondemagegnehu E; Quick J; Suzuki Y
    Qual Assur; 2003; 10(1):11-27. PubMed ID: 12746156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines and medicines for the world's poorest. Quality of vaccines and medicines must be monitored.
    Arya SC
    BMJ; 2000 Sep; 321(7264):834. PubMed ID: 11009543
    [No Abstract]   [Full Text] [Related]  

  • 36. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 37. PDA comments: active pharmaceutical ingredients/guidance. PDA Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1997; 51(3):137-8. PubMed ID: 9203828
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale drug therapy: reasons for failure and suggestions for its implementation.
    Mathur GP; Kushwaha KP; Mathur S
    Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879
    [No Abstract]   [Full Text] [Related]  

  • 39. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.